nordefrin has been researched along with Obesity in 1 studies
Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fluegge, K | 1 |
1 other study available for nordefrin and Obesity
| Article | Year |
|---|---|
The possible role of air pollution in the link between ADHD and obesity.
Topics: Air Pollutants; Air Pollution; alpha7 Nicotinic Acetylcholine Receptor; Attention Deficit Disorder w | 2016 |